Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun 15;207 Suppl 2(Suppl 2):S85-92.
doi: 10.1093/infdis/jit115.

Development of antiretroviral resistance in children with HIV in low- and middle-income countries

Felicity Fitzgerald  1 , Martina Penazzato, Diana Gibb
Affiliations
Review

Development of antiretroviral resistance in children with HIV in low- and middle-income countries

Felicity Fitzgerald et al. J Infect Dis. .

Abstract

With antiretroviral therapy (ART) recommended by the World Health Organization (WHO) for children aged <2 years with human immunodeficiency virus (HIV) and continuing global ART roll-out, ART coverage in children is rising. However ART coverage in children lags considerably behind that in adults (28% vs 58%). Long duration of therapy needed for HIV-infected children requires maximal efficacy, minimal toxicity, and prevention of development of drug resistance. This requires consideration of ways to improve sequencing of regimens during childhood to minimize development of resistance and treatment failure. We consider aspects of virological failure and development of resistance in vertically HIV-infected children in resource-limited settings. We review evidence guiding choices of first- and second-line ART, the impact of drugs given to prevent mother-to-child transmission, adherence issues and, availability of appropriate drug formulations. Recommendations made during the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)/WHO meeting (October 2012) are summarized.

Keywords: HIV; antiretroviral therapy; children; mother-to-child transmission; resistance.

PubMed Disclaimer

References

    1. Joint United Nations Programme on HIV/AIDS. Geneva, Switzerland: UNAIDS; 2012. UNAIDS Report on the global AIDS epidemic 2012.
    1. Geneva, Switzerland: WHO; 2010. WHO. Antiretroviral therapy for HIV infection in infants and children. Recommendations for a public health approach (2010 version)
    1. Sohn AH, Nuttall JJ, Zhang F. Sequencing of antiretroviral therapy in children in low- and middle-income countries. Curr Opin HIV AIDS. 2010;5:54–60. - PubMed
    1. DA Cromwell E., Dube Q, Low D, Van Rie A. Barriers to Participation in Early Infant Diagnosis and Treatment of HIV: Malawi. 20th Conference on Retroviruses and Opportunistic Infections. Georgia World Congress Centre, Atlanta. 2013 Paper 914.
    1. Castro H, Judd A, Gibb DM, et al. Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Lancet. 2011;377:1580–7. - PMC - PubMed

Publication types

MeSH terms